Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:337-341, 2002
© 2002 European Society for Medical Oncology

News

Do you Euro?

Following up on last month’s news, one has by now become accustomed to this new currency. Its introduction, as we write, seems a success, with >85% of the old currencies already withdrawn by mid-January, while it had been expected that double circulation would last until the end of January and was actually authorized in many countries until the middle or end of February. Physicians have also had to face some adaptation issues, in France only 25% had modified their computer programs in order to be able to send their bills to the Social Security in Euros by mid-January. They were given a further delay for this change until February 17. While complaints of ‘hidden’ price hikes have been common, one can be certain that this will not be possible for medical bills. At least in France, where GPs have been going from strike to strike in order to influence the . . . [Full Text of this Article]

Pharma industry tricks continue in biotechnology

Pharma unhappy, of course, but the Brazilian government continues to promote generics

Stem cells: more about the ‘monster of Loch Ness’

Lung cancer: more light on the differences

Tomato juice and prostate cancer: or is it about vodka?

About failures in medical systems

Erbitux® is not a herbal medicine, but maybe some company managers need herbal aid...

Awards, appointments

Perhaps not everyone knows that...

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?